StableX (SBLX) director gets 22,723 options at $6.25
StableX Technologies, Inc. (SBLX) director Wayne Walker reported an option grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
StableX Technologies, Inc. (SBLX) director Wayne Walker reported an option grant. On 10/31/2025, he received 22,723 employee stock options with a $6.25 exercise price.
The grant vests 75% at the date of grant and 25% on December 31, 2025, provided he continues to provide services to the company on that date. Following the transaction, 22,723 derivative securities were beneficially owned on a direct basis.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy | 22,723 | $0.00 | $0.00 |
Footnotes (1)
- F1. The stock options vest as follows: (i) 75% vested upon the date of grant; and (ii) 25% will vest on December 31, 2025, provided that the Reporting Person remains employed by or providing services to the Issuer on the applicable vesting date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did StableX (SBLX) disclose in this Form 4?
What is the vesting schedule for the SBLX options grant?
How many derivative securities are owned after the transaction?
What is the ownership form of the reported securities?
What role does the reporting person have at StableX (SBLX)?
What is the exercise price of the reported options?
AI-generated analysis. How Rhea-AI works. Not financial advice.